Original InvestigationAssociation of Phosphodiesterase-5 Inhibitors Versus Alprostadil With Survival in Men With Coronary Artery Disease
Under a Creative Commons license
open access
Central Illustration
Key Words
cardiovascular disease
coronary artery disease
phosphodiesterase 5 inhibitors
mortality
risk
Abbreviations and Acronyms
ACE
angiotensin-converting enzyme
ARB
angiotensinogen receptor blocker
CABG
coronary artery bypass surgery
CAD
coronary artery disease
CCB
calcium-channel blocker
ED
erectile dysfunction
MACE
major adverse cardiac events
MI
myocardial infarction
PAD
peripheral arterial disease
PCI
percutaneous coronary intervention
PDE5i
phosphodiesesterase-5 inhibitor
q
quintile
Cited by (0)
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
© 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.